CUSIP 92840H400COMVTGNQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
55 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 3.06M | $2.03M | 0 | Held |
| 2 | Tcg Crossover Management, LLC | 2.68M | $1.77M | 0 | Held |
| 3 | Vanguard Group Inc | 1.82M | $1.21M | +137.0K | Added |
| 4 | Adar1 Capital Management, LLC | 623.6K | $412.7K |
| +510.5K |
| Added |
| 5 | Jane Street Group, LLC | 527.1K | $348.9K | +224.4K | Added |
| 6 | Ikarian Capital, LLC | 519.1K | $343.6K | −101.8K | Reduced |
| 7 | Blackrock, Inc. | 422.8K | $279.8K | −369 | Reduced |
| 8 | Geode Capital Management, LLC | 352.8K | $233.6K | +54.6K | Added |
| 9 | Luminus Management LLC | 350.0K | $231.7K | +350.0K | New |
| 10 | Susquehanna International Group, LLP | 334.8K | $221.6K | +249.2K | Added |
See every fund holding Vistagen Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders